Summary of Purpose
To compare the effects of ticlopidine hydrochloride with those of aspirin on the risk of recurrent stroke or death.Read More →
The following dates are available for this trial. Trial information last updated on 19 October 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Syntex Research, Palo Alto, CA
Randomized, stratified, double-blind trial of 3069 patients at 56 centers in the U.S. and Canada. Patients were stratified at each center by history of ischemic cardiovascular disease, the occurrence of a moderate or major stroke more than three months before entry, and sex.